Net Cash Provided by (Used in) Financing Activities in USD of Kraig Biocraft Laboratories, Inc from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Kraig Biocraft Laboratories, Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • Kraig Biocraft Laboratories, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $158K.
  • Kraig Biocraft Laboratories, Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$35.2K, a 41.3% increase from 2023.
  • Kraig Biocraft Laboratories, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$60K, a 102% decline from 2022.
  • Kraig Biocraft Laboratories, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3.4M, a 12.5% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Kraig Biocraft Laboratories, Inc Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $158K +$173K 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q1 2024 -$15K $0 0% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q1 2023 -$15K -$2.07M -101% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q1 2022 $2.05M +$1.53M +289% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q1 2021 $529K +$244K +85.5% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q1 2020 $285K -$834K -74.5% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q1 2019 $1.12M +$1M +873% 01 Jan 2019 31 Mar 2019 10-Q 21 Apr 2020
Q1 2018 $115K -$35K -23.3% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019
Q1 2017 $150K -$50K -25% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018
Q1 2016 $200K +$200K 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q1 2015 $0 -$399K -100% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q1 2014 $399K +$150K +60% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q1 2013 $249K +$150K +152% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q1 2012 $99.1K -$99.8K -50.2% 01 Jan 2012 31 Mar 2012 10-Q/A 24 Dec 2013
Q1 2011 $199K 01 Jan 2011 31 Mar 2011 10-Q 21 May 2012

Kraig Biocraft Laboratories, Inc Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$35.2K +$24.8K +41.3% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025
2023 -$60K -$3.46M -102% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025
2022 $3.4M -$486K -12.5% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 $3.89M +$1.94M +99.6% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023
2020 $1.95M +$647K +49.7% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2022
2019 $1.3M +$1.06M +437% 01 Jan 2019 31 Dec 2019 10-K 12 Mar 2021
2018 $242K -$238K -49.6% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020
2017 $480K -$595K -55.3% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 $1.08M +$325K +43.3% 01 Jan 2016 31 Dec 2016 10-K 23 Mar 2018
2015 $750K -$396K -34.6% 01 Jan 2015 31 Dec 2015 10-K 22 Mar 2017
2014 $1.15M +$101K +9.64% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 $1.05M +$624K +148% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 $421K -$245K -36.8% 01 Jan 2012 31 Dec 2012 10-K 15 Apr 2014
2011 $666K +$377K +130% 01 Jan 2011 31 Dec 2011 10-K/A 24 Dec 2013
2010 $290K 01 Jan 2010 31 Dec 2010 10-K 12 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.